Last Updated: September 25, 2026

Aiping Pharm Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for AIPING PHARM INC

AIPING PHARM INC has fifty-three approved drugs.

Summary for Aiping Pharm Inc

US Patents:	0
Tradenames:	49
Ingredients:	47
NDAs:	53

Drugs and US Patents for Aiping Pharm Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aiping Pharm Inc	SORINE	sotalol hydrochloride	TABLET;ORAL	075500-004	Apr 27, 2001	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Aiping Pharm Inc	CYCLOBENZAPRINE HYDROCHLORIDE	cyclobenzaprine hydrochloride	TABLET;ORAL	072854-001	Nov 19, 1991		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Aiping Pharm Inc	GUANFACINE HYDROCHLORIDE	guanfacine hydrochloride	TABLET;ORAL	216399-001	Jun 8, 2022	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Aiping Pharm Inc	METHIMAZOLE	methimazole	TABLET;ORAL	040547-001	Feb 18, 2005	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Aiping Pharm Inc	FLUVOXAMINE MALEATE	fluvoxamine maleate	TABLET;ORAL	075888-001	Nov 29, 2000	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Aiping Pharm Inc	AMITRIPTYLINE HYDROCHLORIDE	amitriptyline hydrochloride	TABLET;ORAL	212654-003	Sep 29, 2021	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Aiping Pharm Inc	AMITRIPTYLINE HYDROCHLORIDE	amitriptyline hydrochloride	TABLET;ORAL	212654-004	Sep 29, 2021	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Aiping Pharm Inc

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.